A new method to address verification bias in studies of clinical screening tests: cervical cancer sc...
A new method to address verification bias in studies of clinical screening tests: cervical cancer screening assays as an example
About this item
Full title
Author / Creator
Publisher
New York, NY: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York, NY: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Abstract Objectives Studies to evaluate clinical screening tests often face the problem that the “gold standard” diagnostic approach is costly and/or invasive. It is therefore common to verify only a subset of negative screening tests using the gold standard method. However, undersampling the screen negatives can lead to substantial overestimation...
Alternative Titles
Full title
A new method to address verification bias in studies of clinical screening tests: cervical cancer screening assays as an example
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3946800
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3946800
Other Identifiers
ISSN
0895-4356
E-ISSN
1878-5921
DOI
10.1016/j.jclinepi.2013.09.013
